ml 792 Search Results


ml 792  (MedChemExpress)
95
MedChemExpress ml 792
Ml 792, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ml 792/product/MedChemExpress
Average 95 stars, based on 1 article reviews
ml 792 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
sae inhibitor ml792  (TargetMol)
90
TargetMol sae inhibitor ml792
Sae Inhibitor Ml792, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sae inhibitor ml792/product/TargetMol
Average 90 stars, based on 1 article reviews
sae inhibitor ml792 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
naltrexone  (Cerilliant Corporation)
91
Cerilliant Corporation naltrexone
Naltrexone, supplied by Cerilliant Corporation, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/naltrexone/product/Cerilliant Corporation
Average 91 stars, based on 1 article reviews
naltrexone - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier
ml-792  (Takeda)
90
Takeda ml-792
Ml 792, supplied by Takeda, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ml-792/product/Takeda
Average 90 stars, based on 1 article reviews
ml-792 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sumo e1 inhibitor ml-792  (MedKoo Inc)
90
MedKoo Inc sumo e1 inhibitor ml-792
RFWD3 simulates ubiquitylation of proteins on ssDNA (A) Fpg bacterial glycosylase was crosslinked to either double-stranded (pFpg) or single-stranded DNA (pFpg ssDNA ) and added to SPRTN-depleted non-licensing egg extracts. DPC pull-down under stringent conditions was performed at the indicated time points, and samples were blotted against crosslinked Fpg. Slow mobility bands represent ubiquitylated Fpg species (see B). (B) pFpg ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin <t>E1</t> inhibitor was added where indicated. Plasmids were recovered, and samples were blotted against Fpg as in (A). (C) pFpg ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (also depleted of SPRTN) for the indicated time points and samples processed as in (A). (D) Generation of an AP site on ssDNA (pAP ssDNA ) to induce HMCES crosslinking. (E) pAP ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin E1 inhibitor was added where indicated. Plasmids were recovered, and proteins were blotted against HMCES. The black dot indicates sumoylated HMCES (see F). (F) pAP ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (depleted of SPRTN), and ubiquitin E1 inhibitor or <t>SUMO</t> E1 inhibitor was added where indicated. Plasmids were recovered and analyzed as in (D). (G) Model illustrating the role of RFWD3 in gap-filling DNA synthesis (see ).
Sumo E1 Inhibitor Ml 792, supplied by MedKoo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sumo e1 inhibitor ml-792/product/MedKoo Inc
Average 90 stars, based on 1 article reviews
sumo e1 inhibitor ml-792 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
sumo-e1 inhibitor ml-792  (Axon Medchem LLC)
90
Axon Medchem LLC sumo-e1 inhibitor ml-792
RFWD3 simulates ubiquitylation of proteins on ssDNA (A) Fpg bacterial glycosylase was crosslinked to either double-stranded (pFpg) or single-stranded DNA (pFpg ssDNA ) and added to SPRTN-depleted non-licensing egg extracts. DPC pull-down under stringent conditions was performed at the indicated time points, and samples were blotted against crosslinked Fpg. Slow mobility bands represent ubiquitylated Fpg species (see B). (B) pFpg ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin <t>E1</t> inhibitor was added where indicated. Plasmids were recovered, and samples were blotted against Fpg as in (A). (C) pFpg ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (also depleted of SPRTN) for the indicated time points and samples processed as in (A). (D) Generation of an AP site on ssDNA (pAP ssDNA ) to induce HMCES crosslinking. (E) pAP ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin E1 inhibitor was added where indicated. Plasmids were recovered, and proteins were blotted against HMCES. The black dot indicates sumoylated HMCES (see F). (F) pAP ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (depleted of SPRTN), and ubiquitin E1 inhibitor or <t>SUMO</t> E1 inhibitor was added where indicated. Plasmids were recovered and analyzed as in (D). (G) Model illustrating the role of RFWD3 in gap-filling DNA synthesis (see ).
Sumo E1 Inhibitor Ml 792, supplied by Axon Medchem LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sumo-e1 inhibitor ml-792/product/Axon Medchem LLC
Average 90 stars, based on 1 article reviews
sumo-e1 inhibitor ml-792 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ml-792  (Clinisciences)
90
Clinisciences ml-792
RFWD3 simulates ubiquitylation of proteins on ssDNA (A) Fpg bacterial glycosylase was crosslinked to either double-stranded (pFpg) or single-stranded DNA (pFpg ssDNA ) and added to SPRTN-depleted non-licensing egg extracts. DPC pull-down under stringent conditions was performed at the indicated time points, and samples were blotted against crosslinked Fpg. Slow mobility bands represent ubiquitylated Fpg species (see B). (B) pFpg ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin <t>E1</t> inhibitor was added where indicated. Plasmids were recovered, and samples were blotted against Fpg as in (A). (C) pFpg ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (also depleted of SPRTN) for the indicated time points and samples processed as in (A). (D) Generation of an AP site on ssDNA (pAP ssDNA ) to induce HMCES crosslinking. (E) pAP ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin E1 inhibitor was added where indicated. Plasmids were recovered, and proteins were blotted against HMCES. The black dot indicates sumoylated HMCES (see F). (F) pAP ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (depleted of SPRTN), and ubiquitin E1 inhibitor or <t>SUMO</t> E1 inhibitor was added where indicated. Plasmids were recovered and analyzed as in (D). (G) Model illustrating the role of RFWD3 in gap-filling DNA synthesis (see ).
Ml 792, supplied by Clinisciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ml-792/product/Clinisciences
Average 90 stars, based on 1 article reviews
ml-792 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
exogenous surfactant survanta1  (Abbott Laboratories)
90
Abbott Laboratories exogenous surfactant survanta1
RFWD3 simulates ubiquitylation of proteins on ssDNA (A) Fpg bacterial glycosylase was crosslinked to either double-stranded (pFpg) or single-stranded DNA (pFpg ssDNA ) and added to SPRTN-depleted non-licensing egg extracts. DPC pull-down under stringent conditions was performed at the indicated time points, and samples were blotted against crosslinked Fpg. Slow mobility bands represent ubiquitylated Fpg species (see B). (B) pFpg ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin <t>E1</t> inhibitor was added where indicated. Plasmids were recovered, and samples were blotted against Fpg as in (A). (C) pFpg ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (also depleted of SPRTN) for the indicated time points and samples processed as in (A). (D) Generation of an AP site on ssDNA (pAP ssDNA ) to induce HMCES crosslinking. (E) pAP ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin E1 inhibitor was added where indicated. Plasmids were recovered, and proteins were blotted against HMCES. The black dot indicates sumoylated HMCES (see F). (F) pAP ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (depleted of SPRTN), and ubiquitin E1 inhibitor or <t>SUMO</t> E1 inhibitor was added where indicated. Plasmids were recovered and analyzed as in (D). (G) Model illustrating the role of RFWD3 in gap-filling DNA synthesis (see ).
Exogenous Surfactant Survanta1, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/exogenous surfactant survanta1/product/Abbott Laboratories
Average 90 stars, based on 1 article reviews
exogenous surfactant survanta1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
2-d08  (MedChemExpress)
93
MedChemExpress 2-d08
RFWD3 simulates ubiquitylation of proteins on ssDNA (A) Fpg bacterial glycosylase was crosslinked to either double-stranded (pFpg) or single-stranded DNA (pFpg ssDNA ) and added to SPRTN-depleted non-licensing egg extracts. DPC pull-down under stringent conditions was performed at the indicated time points, and samples were blotted against crosslinked Fpg. Slow mobility bands represent ubiquitylated Fpg species (see B). (B) pFpg ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin <t>E1</t> inhibitor was added where indicated. Plasmids were recovered, and samples were blotted against Fpg as in (A). (C) pFpg ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (also depleted of SPRTN) for the indicated time points and samples processed as in (A). (D) Generation of an AP site on ssDNA (pAP ssDNA ) to induce HMCES crosslinking. (E) pAP ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin E1 inhibitor was added where indicated. Plasmids were recovered, and proteins were blotted against HMCES. The black dot indicates sumoylated HMCES (see F). (F) pAP ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (depleted of SPRTN), and ubiquitin E1 inhibitor or <t>SUMO</t> E1 inhibitor was added where indicated. Plasmids were recovered and analyzed as in (D). (G) Model illustrating the role of RFWD3 in gap-filling DNA synthesis (see ).
2 D08, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/2-d08/product/MedChemExpress
Average 93 stars, based on 1 article reviews
2-d08 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

Image Search Results


RFWD3 simulates ubiquitylation of proteins on ssDNA (A) Fpg bacterial glycosylase was crosslinked to either double-stranded (pFpg) or single-stranded DNA (pFpg ssDNA ) and added to SPRTN-depleted non-licensing egg extracts. DPC pull-down under stringent conditions was performed at the indicated time points, and samples were blotted against crosslinked Fpg. Slow mobility bands represent ubiquitylated Fpg species (see B). (B) pFpg ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin E1 inhibitor was added where indicated. Plasmids were recovered, and samples were blotted against Fpg as in (A). (C) pFpg ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (also depleted of SPRTN) for the indicated time points and samples processed as in (A). (D) Generation of an AP site on ssDNA (pAP ssDNA ) to induce HMCES crosslinking. (E) pAP ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin E1 inhibitor was added where indicated. Plasmids were recovered, and proteins were blotted against HMCES. The black dot indicates sumoylated HMCES (see F). (F) pAP ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (depleted of SPRTN), and ubiquitin E1 inhibitor or SUMO E1 inhibitor was added where indicated. Plasmids were recovered and analyzed as in (D). (G) Model illustrating the role of RFWD3 in gap-filling DNA synthesis (see ).

Journal: Molecular Cell

Article Title: The ubiquitin ligase RFWD3 is required for translesion DNA synthesis

doi: 10.1016/j.molcel.2020.11.029

Figure Lengend Snippet: RFWD3 simulates ubiquitylation of proteins on ssDNA (A) Fpg bacterial glycosylase was crosslinked to either double-stranded (pFpg) or single-stranded DNA (pFpg ssDNA ) and added to SPRTN-depleted non-licensing egg extracts. DPC pull-down under stringent conditions was performed at the indicated time points, and samples were blotted against crosslinked Fpg. Slow mobility bands represent ubiquitylated Fpg species (see B). (B) pFpg ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin E1 inhibitor was added where indicated. Plasmids were recovered, and samples were blotted against Fpg as in (A). (C) pFpg ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (also depleted of SPRTN) for the indicated time points and samples processed as in (A). (D) Generation of an AP site on ssDNA (pAP ssDNA ) to induce HMCES crosslinking. (E) pAP ssDNA was incubated in SPRTN-depleted non-licensing extracts, and ubiquitin E1 inhibitor was added where indicated. Plasmids were recovered, and proteins were blotted against HMCES. The black dot indicates sumoylated HMCES (see F). (F) pAP ssDNA was incubated in mock- or RFWD3-depleted non-licensing extracts (depleted of SPRTN), and ubiquitin E1 inhibitor or SUMO E1 inhibitor was added where indicated. Plasmids were recovered and analyzed as in (D). (G) Model illustrating the role of RFWD3 in gap-filling DNA synthesis (see ).

Article Snippet: SUMO E1 inhibitor (ML-792; Medkoo Biosciences) was supplemented to egg extracts at the final concentration of 50 μM.

Techniques: Incubation, Ubiquitin Proteomics, DNA Synthesis

Journal: Molecular Cell

Article Title: The ubiquitin ligase RFWD3 is required for translesion DNA synthesis

doi: 10.1016/j.molcel.2020.11.029

Figure Lengend Snippet:

Article Snippet: SUMO E1 inhibitor (ML-792; Medkoo Biosciences) was supplemented to egg extracts at the final concentration of 50 μM.

Techniques: Ubiquitin Proteomics, Recombinant, Mutagenesis, Staining, Magnetic Beads, Transfection, Sequencing, Software